About the Journal

SKIN is a bi-monthly, peer-reviewed, online medical journal dedicated to providing an enhanced route to disseminate new dermatologic knowledge on all aspects of cutaneous disease.
Read More

Current Issue

Vol. 4 No. 5 (2020): September Issue and Poster Presentations (2020 Fall Clinical PANP® Conference)

Published: 2020-09-10

In-Depth Reviews

Resident Competition Research Articles

The Impact of Skin Disease on Quality of Life in Rural Communities of Ghana

Caroline W Laggis, Aaron M Secrest, Martin Agyei, Sam Simister, Andrea N Davis, Ty Dickerson, Jamie LW Rhoads

Page 417-423

Sentinel Lymph Node Predictors in Melanoma of Breslow Thickness 0.8-1.0 mm

Luisa Fernanda Christensen, David Carr, Sheena Hill, Elizabeth Ramser, Jaime Abraham Perez, Jeremy Bordeaux

Page 431-437

COVID Concepts

Maskne: Exacerbation or Eruption of Acne During the COVID-19 Pandemic

Tamar A Gomolin, Abigail Cline, Marian Russo

Page 438-439

Chilblains-Like Lesions as a Presenting Manifestation of COVID-19

Victoria Comeau, Marcus Goodman, Carmen Julian, Francesca M Ceci

Page 440-442

Brief Articles

Cetuximab Induced Hidrocystomas: A Case Report

Nicole Nagrani, David E Castillo, Mariya Miteva, Anna Nichols

Page 443-445

Eruptive Oral Mucoceles in a Neonate

Ghassan Niaz, Ellen H de Moll, Lauren Zinns, Bryan Tassavor, Robert G Phelps

Page 446-448

Blistering Rash over Broken Ribs

Kathleen R Graham, Bethany R Rohr, Victor J Marks

Page 449-451

An Atypical Presentation of Pemphigus Vegetans in the Umbilicus

Antonio Jimenez, Paige Hoyer, Michael Wilkerson

Page 452-455

Extensive Tinea Associated with Tofacitinib Therapy Masquerading as New-Onset SCLE

Connor R Buechler, Elena Kurland, Jesse Veenstra

Page 456-459

Pilomatrical Carcinoma in a 70-Year-Old Hispanic Female

Jeffery S Harbold, Richard G Wagner, Rick Lin

Page 460-463

A Rare Case of Angiolymphoid Hyperplasia without Eosinophils, with Review of the Literature

James Ko, Zachary P Nahmias, Patrick S Phelan, Sabra Abner, Kara Blackwell, Andras Schaffer

Page 464-467

Facial Papules in Birt-Hogg-Dubé Syndrome: A Growing Spectrum of Pathologic Findings

Lauren G Yi, Ricardo Guerra, Sam B Wu, Richard H Flowers

Page 468-471

Short Communications

Pruritic Papulonodules Following Tattoo Application

Carlos J Sarriera-Lazaro, Bijan Safai

Page 476-477

Compelling Comments

Delusions of Parasitosis Influenced by Crowdsourcing Diagnostic Platform CrowdMed

Julian Stashower, Katherine Belote, Barrett Zlotoff

Page 481-482

Falling in Hair Love Comes Naturally

Emmanuella Oduguwa, Danyal Tahseen

Page 483

Commentary & Notes

Plant Fiber Contaminants in Morgellons Disease Skin Samples

Marianne J Middelveen, Raphael B Stricker

Page 484-485

Dermatologic History

2020 PANP Fall Clinical Conference® Posters: Psoriasis

An Oral, Selective Tyrosine Kinase 2 Inhibitor, BMS-986165, Reduced Absolute Psoriasis Area and Severity Index in a Phase 2 Trial in Psoriasis

Bruce Strober, Alice Gottlieb, Diamant Thaçi, Luis Puig, Matthew J Colombo, Sundeep Kundu, Renata Kisa, Subhashis Banerjee

Page s27

BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients

Kenneth Gordon, Kim Papp, Melinda Gooderham, Akimichi Morita, Peter Foley, Diamant Thaçi, Sundeep Kundu, Renata Kisa, Lan Wei, Subhashis Banergee

Page s28

Real World Patient Perceptions of the use of Calcipotriene Foam 0.005% in the Treatment of Plaque Psoriasis

Francisco Kerdel, Christina Don, Renata Block, Caitlin Lewis, Rhonda Schreiber

Page s33

Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from Resurface 1 and Resurface 2

Richard G Langley, Jeffrey Crowley, Melinda Gooderham, Kim A Papp, Neil J Korman, Lynda Spelman, Atsuyuki Igarashi, Mamitaro Ohtsuki, Aditya K Gupta, Paul Yamauchi, Jeffrey Parno, Alan M Mendelsohn, Stephen J Rozzo, Kimberly Eads

Page s39

Early and Maintained Response Levels in Psoriasis Patients Treated with Tildrakizumab

Kim A Papp, Jensen Yeung, Neil Shear, Lorne Albrecht, Charles Lynde, Jingchuan Zhang, Yang Zhao, Jeff Parno, Alan M Mendelsohn, Melinda Gooderham

Page s41

Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)

K Gordon, R B Warren, A B Gottlieb, A Blauvelt, D Thaçi, C Leonardi, Y Poulin, M Boehnlein, S Kavanagh, C Arendt, K Reich

Page s44

Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies

A Blauvelt, C Paul, P van de Kerkhof, R B Warren, A B Gottlieb, R G Langley, F Brock, C Arendt, M Boehnlein, M Lebwohl, K Reich

Page s46

Efficacy of Tapinarof Cream by Body Region in Subjects With Plaque Psoriasis in a Phase 2b Randomized Controlled Study

Robert Bissonnette, Linda Stein Gold, Leon Kircik, Stephen Tyring, Anna Tailman, April Armstrong

Page s47

Atopic Dermatitis

Dupilumab Decreases Blood Biomarkers in Adolescents With Moderate-to-Severe Atopic Dermatitis: Data From a Phase 3 Trial (LIBERTY AD ADOL)

Eric L Simpson, Hiroyuki Fujita, Kazuhiko Arima, Jennifer Hamilton, Yufang Lu, Ana B Rossi, Ashish Bansal

Page s49

Acne & Rosacea

Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-Blind Clinical Trials

Angela Moore, Suzanne Bruce, Neil Sadick, Eduardo Tschen, Philip Werschler, Sunil Dhawan, Douglas Farsha, Michael Gold, Scott Guenthner, Steve Kempers, Leon Kircik, Jennifer Parish, Marta Rendon, Phoebe Rich, Linda Stein-Gold, Stephen Tyring, Robert Weiss, Adnan Nasir, Carsten Schmitz, Terry Boodhoo, Alexandre Kaoukhov, David Berk, Fran Cook-Bolden, Ayman Grada

Page s52

Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris

David M Pariser, Lawrence J Green, Edward L Lain, Carsten Schmitz, Amy S Chinigo, Brian McNames, David R Berk, Jamison Hoffman, Ayman Grada

Page s53

Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies

James Q Del Rosso, Linda Stein Gold, Leon Kircik, Neal D Bhatia, Neil Sadick, Matthew Zirwas, Edward Lain, Iain Stuart

Page s55

Trifarotene 50 µg/G Cream for Treatment of Acne Vulgaris – A Summary of Two Randomized Trials and a Long-Term Safety Study

Jerry Tan, James Del Rosso, Jonathan Weiss, Linda Stein Gold, Fran Cook-Bolden, Lawrence Eichenfeld, Emil Tanghetti, Alessandra Alió Saenz, Faiz Ahmad

Page s57

Real World Patient Perceptions of the use of Tazarotene 0.1% Foam in the Treatment of Acne Vulgaris

James Q Del Rosso, Corey L Hartman, Caitlin Lewis, Rhonda Schreiber

Page s58

Efficacy and Safety of a Novel Tazarotene 0.045% Lotion in Females and Males With Moderate-to-Severe Acne

Hilary E Baldwin, Lawrence Green, Leon Kircik, Ashlie M Caronia, Eric Guenin

Page s60

Nail Unit Disorders

Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis in Pediatric Patients

Lawrence F Eichenfield, Boni Elewski, Jeffrey L Sugarman, Ted Rosen, Aditya Gupta, Wendy Cantrell, Radhakrishnan Pillai, Abby Jacobson

Page s61

Dermatopharmacology

Skin Cancer

View All Issues